Participate in the COVID-19 Genomic Study

In response to the worldwide COVID-19 outbreak, Silverberry Genomix has launched a genomic study to better understand the current pandemic and improve a preventative response for the future.

You can participate in the study by answering a few questions (takes approximately 3 minutes) and include your DNA file for the study. While we are not determining whether you have or been exposed to COVID-19 in the past, your information will help us better understand your possible vulnerability or resistance to it.


COVID-19 Genomic Study Scientific Committee


Ahmad Salehi, Ph.D., M.D.

Clinical Professor, Stanford Medical School, Head of Silverberry Scientific Advisory Board

Bio

Navid Madani, Ph.D.

Sr. Scientist, DANA-FARBER Cancer Institute,
Harvard Medical School

Bio

Raya Khanin, Ph.D.

Sr. Scientist, Computential Biology
Associate Professor at the Memorial Sloan Kettering Cancer Center

Bio


How is the study conducted

The COVID-19 Genomic Study intends to identify genomic susceptibility that alters either the rate of infection or the severity of the disease in response to coronavirus exposure. 

The study involves healthy participants that may or may not be exposed to COVID-19. It will look into the effects of various factors including age, comorbidity and lifestyle choices such as smoking in the occurrence of COVID-19 symptoms. 

Collection of pre and post universal exposure data from a large number of people in different communities would help us effectively learn and come up with recommendations to counter future pandemics.  Study participants will have their genome analyzed for the presence of protective or susceptibility factors. Users with an existing DNA file can also upload their corresponding files. New users can use the Silverberry DNA Testing Kit with the at-home using a saliva swab. The study volunteers will participate in an ongoing survey and undergo analysis of their genetic markers. The goal of the study is to identify genomic variants that affect diseases in the healthier participants and that can protect them against more severe diseases. We hope to use this knowledge for the development of novel therapies.

 


Frequently Asked Questions about the Novel Coronavirus (COVID-19)

As the world copes with the impact of the novel coronavirus (COVID-19) pandemic, we know that you have a lot of questions about what it means for you and the people you care about. At Silverberry, we consider education and being informed as the best way to take care of the wellbeing of our users and community. We have gathered the most common questions you might have, aside news and stats, about the virus and how best to protect yourself.

If you have any questions that is not answered in this page, email it to faq@silverberrygenomix.com. We will do our best to gather information from experts and post it here. We will continue to update this page to respond to the evolving situation.

 

Protecting yourself and others from COVID-19

What is COVID-19 and how does it spread?

Have More Questions?


COVID-19 Research Update

In the times of pandemics, novel ways to care for patients remotely via telemedicine. [link]

Tracking medical supply chain using blockchain [Link]

More than 99% of Italy’s coronavirus fatalities were people who suffered from previous medical conditions [Link]

The Cepheid’s COVID-Test results will be available within 45 minutes, approved by FDA to be released by end of the month. [Link]

Evolution selects for ‘loners’ that hang back from collective behaviour—at least in slime molds. [Link]

 

*Disclaimer:

Silverberry does not offer a diagnostic test, screening, monitoring or any services to cure COVID-19 or any other diseases. Linking to articles does not mean endorsing them. If you experience any COVID-19 virus symptoms, contact your healthcare provider or authorities.  This page and its subpages is for informational purposes only.  See Silverberry Terms of Use and Privacy Policy for more information.